Transaction #24246 · Form 4 · 0001993684-25-000004
Immunome Inc. · Gift received · Common Stock
Immunome Inc. · Transacted December 19, 2025 · Filed December 22, 2025
What does this filing report?
An SEC Form 4 filing for Immunome Inc. records a gift received involving Common Stock on December 19, 2025. The reported quantity was 1,000. The filing date is December 22, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Immunome Inc.
- Company CIK
- 0001472012
- Security type
- Non-derivative
- Acquisition type
- Gift received · Code G
- Quantity acquired
- 1,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 1,000
- Ownership description
- As Custodian for Child 1
- SEC acceptance time
- Dec 22, 2025, 7:43 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Higgins Jack ↗
Chief Scientific Officer
CIK 0001993684
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.
- F2
- The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the "Lock-up Agreement"). The transferee has agreed to be bound by the terms of the Lock-up Agreement.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.